LivePerson Stockholders Sign Off on SoundHound AI Takeover

LivePerson stockholders voted to approve the company’s acquisition by SoundHound AI at a special meeting held on September 2, 2026, clearing the deal’s final shareholder hurdle and putting the transaction on track to close within days. LivePerson announced the result through its investor relations channel, stating that the transaction is expected to close on September…

Read More

iPronics Raises $125M Series B to Scale Optical Networking for AI Data Centers

iPronics has raised $125 million in Series B funding to accelerate the commercial deployment of its programmable optical networking technology for artificial intelligence (AI) data centers. The round was co-led by Maverick Silicon and Light Street Capital, with NVIDIA joining as an investor alongside Triatomic Capital, Bosch Ventures, Catalight Capital, the European Innovation Council Fund…

Read More

Huskeys Raises $27M Series A to Build the Security Control Layer for the AI Driven Network

Huskeys has raised $27 million in Series A funding, led by Blackstone Innovations Investments, as the cybersecurity startup looks to address a growing problem created by fragmented cloud infrastructure and rapidly increasing AI-driven internet traffic. The round brings Huskeys’ total funding to $35 million following an earlier $8 million seed round. The Wall Street Journal…

Read More

CPP Investments, Equinix Close $4B atNorth Deal as Partners Group Keeps 10%

Canada Pension Plan Investment Board (CPP Investments) and Equinix, Inc. have completed their US$4 billion acquisition of atNorth, the Nordic high-density colocation and built-to-suit data center developer and operator, the organizations announced on September 2, 2026. The close finalizes a deal first signed in February and reshapes the ownership structure around one of the region’s…

Read More

Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist and Patient Data

Owkin announced on September 2, 2026 that it has entered a license agreement with Boehringer Ingelheim covering K Pro, Owkin’s AI Scientist for biopharma research, together with multimodal patient data aimed at speeding discovery across multiple indications in oncology and immunology. Under the agreement, Owkin will license multimodal oncology data to Boehringer Ingelheim and will…

Read More
Back To Top